Repeatability of tumor blood flow quantification with 82Rubidium PET/CT in prostate cancer — a test-retest study

Autor: Mads Ryø Jochumsen, Kirsten Bouchelouche, Katrine Bødkergaard Nielsen, Jørgen Frøkiær, Michael Borre, Jens Sörensen, Lars Poulsen Tolbod

Publikováno v: EJNMMI Research, Vol 9, Iss 1, Pp 1-7 (2019)

Abstract Background Non-invasive tumor blood flow (TBF) quantification is a candidate approach for risk stratification and monitoring of prostate cancer patients. Validation data have recently been published on prostate TBF measurement with the widel

Externí odkaz: https://doaj.org/article/0eeebd329f324959990f518ecdc1b7f0

Skeletal 'Superscan' With 11C-Methionine PET/CT in Polycythemia Vera

Autor: Mads Ryø Jochumsen, Michael Alle Madsen, Anne Kirstine Arveschoug

Publikováno v: Jochumsen, M R, Madsen, M A & Arveschoug, A K 2023, ' Skeletal “Superscan” With 11C-Methionine PET/CT in Polycythemia Vera ', Clinical Nuclear Medicine, vol. 48, no. 4, pp. E198-E199 . https://doi.org/10.1097/RLU.0000000000004559

11C-methionine PET/CT for parathyroid adenoma localization on a 60-year-old woman known with polycythemia vera revealed highly methionine-avid red bone marrow, an uptake pattern that has previously been described in hematological disease such as mult

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e74fde5f626b1ef6f93e04018e160b
https://pure.au.dk/portal/da/publications/skeletal-superscan-with-11cmethionine-petct-in-polycythemia-vera(4c3c7042-5f5f-4896-823d-ba88c945afc4).html

Extracardiac findings with increased perfusion during clinical O-15-H

Autor: Mads Ryø, Jochumsen, David Lyse, Overgaard, Mikkel Holm, Vendelbo, Michael Alle, Madsen, Lars Poulsen, Tolbod, Lars Christian, Gormsen, Trine Ørhøj, Barkholt

Publikováno v: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Coincidental extracardiac findings with increased perfusion were reported during myocardial perfusion imaging (MPI) with various retention radiotracers. Clinical parametric O-15-HAll patients (2963) were scanned with O-15-HMalignant and benign extrac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9dfe3d7bca83ec07c606e21f13e0397e
https://pubmed.ncbi.nlm.nih.gov/36600173

No Added Value of 18F-Sodium Fluoride PET/CT for the Detection of Bone Metastases in Patients with Newly Diagnosed Prostate Cancer with Normal Bone Scintigraphy

Autor: Niels C. Langkilde, Jørgen Bjerggaard Jensen, Christian Haarmark, Mads Ryø Jochumsen, Lars Jelstrup Petersen, Jesper C. Mortensen, Helle D Zacho, Helle W. Hendel

Publikováno v: Zacho, H, Jochumsen, M R, Langkilde, N C, Mortensen, J C, Haarmark, C, Hendel, H W, Jensen, J B & Petersen, L J 2019, ' No added value of 18 F-sodium fluoride PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer with normal bone scintigraphy ', Journal of Nuclear Medicine, vol. 60, no. 12, pp. 1713-1716 . https://doi.org/10.2967/jnumed.119.229062
Zacho, H D, Jochumsen, M R, Langkilde, N-C, Mortensen, J C, Haarmark, C, Hendel, H W, Jensen, J B & Petersen, L J 2019, ' No added value of 18 F-sodium fluoride PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer with normal bone scintigraphy ', Journal of Nuclear Medicine, vol. 60, no. 12, pp. 1713-1716 . https://doi.org/10.2967/jnumed.119.229062

Aim: To determine if additional 18F-sodium fluoride PET/CT (NaF-PET/CT) improves the prognostic accuracy in the initial staging of prostate cancer patients with normal bone scintigraphy undergoing prostatectomy. Methods: A prospective cohort study ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d03949acb3687a845db565870ade5af
https://doi.org/10.2967/jnumed.119.229062

Tumour blood flow for prediction of human prostate cancer aggressiveness - A study with Rubidium-82 PET, MRI and Na+/K+-ATPase-density

Autor: Kirsten Bouchelouche, Bodil Ginnerup Pedersen, Jørgen Frøkiær, Søren Krag, Lars Poulsen Tolbod, Jens R. Nyengaard, Jens Nørkær Sørensen, Mads Ryø Jochumsen, Michael Borre

Publikováno v: Jochumsen, M R, Sørensen, J, Pedersen, B G, Nyengaard, J R, Krag, S R P, Frøkiær, J, Borre, M, Bouchelouche, K & Tolbod, L P 2021, ' Tumour blood flow for prediction of human prostate cancer aggressiveness-A study with Rubidium-82 PET, MRI and Na+/K+-ATPase-density ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 2, pp. 532-542 . https://doi.org/10.1007/s00259-020-04998-2

Purpose Tumour blood flow (TBF) is a crucial determinant of cancer growth. Recently, we validated Rubidium-82 (82Rb) positron emission tomography (PET) for TBF measurement in prostate cancer (PCa) and found TBF and cancer aggressiveness positively co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95658cafc8e4cb2fe34866c6a1e40784
https://pure.au.dk/portal/da/publications/tumour-blood-flow-for-prediction-of-human-prostate-cancer-aggressiveness--a-study-with-rubidium82-pet-mri-and-nakatpasedensity(e25fdaad-da18-4c7c-9d7f-61c13eef08aa).html